the management of anxiety, depression, ptsd, insomnia and pain
TRANSCRIPT
The Management of Anxiety, Depression, PTSD, Insomnia and Pain
Cranial Electrotherapy Stimulation (CES)
© Copyright 2016 Electromedical Products International, Inc. , Mineral Wells, Texas, USA ALL RIGHTS RESERVED
Josh Briley, Ph.D., FAIS
Financial Disclosure
Josh Briley, Ph.D., FAIS
Relevant Financial Relationship:
• Is an employee of Electromedical Products
International, Inc. (EPII) and receives a salary.
• EPII manufactures and sales Alpha-Stim CES devices
What is Cranial
Electrotherapy Stimulation
(CES)?• It is a noninvasive, safe, and effective form
of neurostimulation that can be performed by
the clinician, or the patient at home, and is
cost effective.
• It sends very tiny electrical signals into the
brain by electrodes.
• In 38 years, no dangerous side effects have
ever been reported.
Feelings Experienced During CES
Treatment Stages
Dosage equals time inversely proportional to current level.
Therefore, less current requires longer treatment time per session.
SLEEPY
AWAKE
TIME
ALERT
20 minutes to
1 or more hours
HEAVY, GROGGY, EUPHORIC (never stop here)
No “brainfog,” vision is
clear and patients feel
energetic as if they
slept soundly all night
LIGHT FEELING
Kirsch, Daniel L. and Nichols, Francine. Cranial electrotherapy stimulation for treatment of anxiety, depression and insomnia.
Psychiatric Clinics of North America. 2013; 36(1):169-176.
(A) Electrical synapses are much faster but get weaker over distances. Gap junctions between pre- and postsynaptic membranes permit current to flow passively through intercellular channels. This current flow initiates or inhibits the generation of postsynaptic action potentials.
(B) Chemical synapses are slower but exhibit gain (strengthening signal). There is no intercellular continuity, and thus no direct flow of current from pre- to postsynaptic cell. Current can only flow across the postsynaptic membrane in response to the secretion of neurotransmitters which open or close postsynaptic ion channels after binding to receptor molecules.
Purves, Dale and Augustine, George J. et al. Neuroscience, 2nd Ed. Sinauer, Sunderland, MA , 2001.
Electrical and
chemical
synapses
differ
fundamentally
in their
transmission
mechanisms
Models of Receptor Activation
21st
Century
The New Theory:
Physical/
Atomic
Electromagnetic
Communication
19th & 20th
Century
The Old Theory:
Structural
Matching;
Chemical/
Molecular
Physical
Communication
The 3D nature of the ligand matches the receptor.
Physical proximity induces receptor conformational
changes which triggers the cascade of events
prompting cell function.
Proximity favors co-resonance of specific
bioelectrical signals with frequencies that perfectly
match the resonance of the receptor to amplify
molecular conformational changes at all steps of
the cascade prompting cell function, even from long
distances (like tuning in a radio).
Benveniste, J. A fundamental basis for the effects of EMFs in biology and medicine: The interface between matter and function. Chapter 13 in Bioelectromagnetic Medicine. Rosch, P and Markov, M, eds. Marcel Dekker, New York, 2004.
Putative Mechanism of CES
Giordano, James. Illustrating how CES works. Insert in
Kirsch, Daniel L. Cranial electrotherapy stimulation for the
treatment of anxiety, depression, insomnia and other
conditions. Natural Medicine. 2006; 23:118-120.
CES engages the serotonergic (5-HT)
raphe nuclei of the brainstem. 5-HT
inhibits brainstem cholinergic (ACh) and
noradrenergic (NE) systems that project
supratentorially. This suppresses thalamo-
cortical activity, arousal, agitation, alters
sensory processing and induces EEG
alpha rhythm. 5-HT can also act directly to
modulate pain sensation in the dorsal
horn of the spinal cord, alter pain
perception, cognition and emotionality
within the limbic forebrain.
Legend:
Blue arrows: inhibitory interactions
Purple arrows: excitatory interactions
X: suppressed pathways/interactions
ACh
LDT
PPN
NE
LC
5-HT
Acetylcholine
Laterodorsal Tegmental Nucleus
of the brainstem
Pediculo-Ponitne nucleus of the
brainstem
Norepinephrine
Locus Dceruleus
Serotonin
QEEG Changes in 30 Subjects Treated with 20 Minutes of CES
There is an increase in alpha activity with a simultaneous decrease in delta.
Blue = decrease Red = increase
Kennerly, Richard. QEEG analysis of cranial electrotherapy: a pilot study.
Journal of Neurotherapy, (8)2, 2004.
Presented at the International Society for Neuronal Regulation conference, September 18-21, 2003, Houston, Texas
Decrease DeltaMore alert
Increase AlphaMore relaxed
Low Resolution Tomography
Paired t-test for 8 Hz LORETA: Significant alpha wave increases after 20 minutes of 0.5 Hz CES
Kennerly, Richard C. Changes in quantitative EEG and low resolution tomography following cranial electrotherapy stimulation.
Ph.D. Dissertation, the University of North Texas. 529 pp., 81 tables, 233 figures, 171 references, 2006.
State (Situational) Anxiety
State anxiety can be effectively treated in a single CES
treatment session.
Results will vary based on initial
anxiety level, length of treatment,
comorbidities and overall patient
health.
This is demonstrated in medical and
dental studies and in mechanistic
studies of EEG and fMRI changes
from a single CES treatment.
Change in Multiple Stress Measures
from a Single CES Treatment
Heffernan, Michael. The effect of a single cranial electrotherapy stimulation on multiple stress measures.
The Townsend Letter for Doctors. 147:60-64, 1995.
Presented at the Eighth International Montreux Congress on Stress,Montreux, Switzerland, February, 1996.
CE
S G
roup
Contr
ols
CE
S G
roup
Contr
ols
CE
S G
roup
Contr
ols
Mu
scle
Te
nsio
n
Mu
scle
Te
nsio
n
Pu
lse
Pu
lse
Te
mp
era
ture
Te
mp
era
ture
-3
-2
-1
0
1
2
3
4
5
Nu
mb
er
of
Scale
Po
ints
of
Imp
rovem
en
t
Stress Measure
P<0.05
Trait (Chronic) Anxiety
May require up to 6 weeks of CES
treatments, 2-3 times per week, to see
significant reduction in trait anxiety and
GAD levels.
Treatment outcome may also depend
on comorbidities such as depression
and insomnia.
Patients diagnosed with Generalized Anxiety Disorder (GAD) have higher
scores on trait anxiety and depression tests, more negative beliefs about
worry, a greater range of worry topics, and more frequent and severe
negative thought intrusions.
Anxiety Improvement in Advanced Cancer Patients
Yennurajalingam S, Kang D-H, Hwu W-J, Padhye NS, Masino C, Dibaj SS, Liu DD, Williams JL, Lu Z, Bruera E. Cranial electrotherapy stimulation for the management of depression, anxiety, sleep disturbance, and pain in patients with advanced cancer: a preliminary study. Journal of Pain and Symptom
Management. 2018; 55(2): 198-206.
8.81
6.89
6.426.24 6.16
5
5.5
6
6.5
7
7.5
8
8.5
9
9.5
Baseline Week 1 Week 2 Week 3 Week 4
Mean anxiety scores in advanced cancer patients
Hospital Anxiety and Depression ScaleN= 33p<0.001
Anxiety
Kim HJ, Kim WY, Lee YS, Chang M, et al. The effect of cranial electrotherapy stimulation on preoperative anxiety and hemodynamic
responses. Korean Journal of Anesthesiology. 2008; 55: 657- 661.
Barclay TH, Barclay RD. A clinical trial of cranial electrotherapy stimulation for anxiety and comorbid depression. Journal of Affective
Disorders. 2014; 164: 171-177. Presented at the American Psychological Association National Conference, Honolulu, HI, July 2013.
Anxiety
Cork, Randall C., Wood, Patrick, Ming, Norbert, Shepherd, Clifton, Eddy, James and Price, Larry. The effect of cranial electrotherapy stimulation
(CES) on pain associated with fibromyalgia. The Internet Journal of Anesthesiology. 2004; 8(2).
Winick, Reid L. Cranial electrotherapy stimulation (CES): A safe and effective low cost means of anxiety control in dental practice.
General Dentistry. 1999; 47(1): 50-55.
Anxiety
Voris, Marshall D. An investigation of the effectiveness of cranial electrotherapy stimulation in the treatment of anxiety disorders among outpatient psychiatric patients, impulse control parolees
and pedophiles. Delos Mind/Body Institute Newsletter. 1995.
Dallas and Corpus Cristi, Texas.
Bystritsky A, Kerwin L and Feusner J. A pilot study of cranial
electrotherapy stimulation for generalized anxiety disorder.
Journal of Clinical Psychiatry. 2008; 69:412-417.
PTSD in a 54 Year Old Male Veteran
Overall Decrease in Severity
of 39% in One Month
PTSD Symptom
Scale – Interview
(PSS-I)PRE POST
PSS-I
(Range: 0-51) 34 13
Re-experiencing
(0-15) 7 2
Avoidance
(0-21) 15 7
Increased Arousal
(0-15) 12 4
Bracciano, Alfred G., Chang, Wen-Pin, Kokesh, Stephanie, Martinez, Abe, Meier , Melissa and Moore, Kathleen.
Cranial Electrotherapy Stimulation in the Treatment of Posttraumatic Stress Disorder:
A Pilot Study of Two Military Veterans. Journal of Neurotherapy. 2012; 16(1): 60-69,.
Childs, Allen and Price, Larry. Cranial electrotherapy stimulation reduces aggression in violent neuropsychiatric patients.
Primary Psychiatry. 2007; 14(3): 50-56. Presented at American Psychiatric Association annual meeting, 2007.
0
200
400
600
800
1000
1200
1400
Aggressive
episodes
Seclusions Restraints PRN Meds
Incid
en
ts
Pre CES
Post CES
3 Month Trial with 48 Severe Aggressive
Neuropsychiatric Patients
The decrease of 271 PRN emergency medicine doses in 3 months
saved more than $12,000 for these medication expenses alone.
44% decrease
p<.001
40%
p<.05
40%
p<.001
42%
p<.01
Insomnia
Insomnia patients usually see results after one treatment.
Or it may take up to 4 weeks of treatment, especially if insomnia is associated with depression.
Typically better results are seen with sleep onset insomnia but CES may also help with sleep continuity for people who do not experience alertness. Treat at least 3 hours before bed.
Insomnia
Lande RG and Gragnani C. Efficacy of cranial electric stimulation for
the treatment of insomnia: A randomized pilot study.
Complementary Therapies in Medicine. 2013; 21(1): 8-13.
Taylor AG, Anderson JG, Riedel SL, Lewis JE, et al. A randomized,
controlled, double-blind pilot study of the effects of cranial electrical
stimulation on activity in brain pain processing regions in individuals
with fibromyalgia. Explore. 2013; 9(1): 32-40.
Insomnia
Lichtbroun, Alan S., Raicer, Mei-Ming C. and Smith, Ray B.
The treatment of fibromyalgia with cranial electrotherapy stimulation.
Journal of Clinical Rheumatology. 2001; 7(2): 72-78.
Depression
Expect a minimum of 3 - 6 weeks of daily CES treatment before significant results are seen
A patient who suffers from anxiety with a depression component will take up to one month to improve as well
After 6 weeks, treat 1 - 2 times per week
Barclay TH, Barclay RD. A clinical trial of cranial electrotherapy stimulation for anxiety and comorbid depression. Journal of Affective Disorders. 2014; 164:171-177. Presented at the American Psychological
Association National Conference, Honolulu, HI, July 2013.
82.2% of the active group reported at least 50% improvement.The active group reported 12 times more improvement than the sham group.
14.51
9.64
8.16.47
13.22
10.229.86 9.96
6
7
8
9
10
11
12
13
14
15
Baseline Week 1 Week 3 Week 5
Ad
just
ed
Me
ans
fro
m B
ase
line
Active Treatment (N=58) Sham Treatment (N=49)
Mean Depression Scores
N = 107
P=0.001
d=0.75
HAM-D
Depression
Chen Y, Yu L, Zhang J, Li L, et al. Results of cranial electrotherapy stimulation to children with mixed anxiety and depressive disorder.
Shanghai Archives of Psychiatry. 2007; 19(4): 203-205.
Barclay TH, Barclay RD. A clinical trial of cranial electrotherapy stimulation for anxiety and comorbid depression. Journal of Affective
Disorders. 2014; 164: 171-177. Presented at the American Psychological Association National Conference, Honolulu, HI, July 2013.
Depression
Amr, Mostafa, El-Wasify, Mahmoud, Elmaadawi, Ahmed, Roberts,
Jeannie, and El-Mallakn, Rif. cranial electrotherapy stimulation for
the treatment of chronically symptomatic bipolar patients.
Journal of ECT. 2013; 29(2): 31-32.
Bystritsky A, Kerwin L and Feusner J. A pilot study of cranial
electrotherapy stimulation for generalized anxiety disorder.
Journal of Clinical Psychiatry. 2008; 69:412-417.
Pain Management
• Acute
• Chronic
• Post-traumatic
Pain relief is cumulative with continued use.
Results are usually seen from the first treatment.
There is no risk of accommodation or
addiction.
Perspective:
The average pain
reduction from
long-term use of
analgesic drugs
is only 32%!
Most of the CES
and MET research
shows effects above
(in addition to)
drug effects.
Tan Gabriel and Jensen Mark P.
Integrating complementary and alternative medicine
(CAM) into multidisciplinary chronic pain treatment.
In Multidisciplinary Chronic Pain Management:
a Guidebook for Program Development
and Excellence of Treatment.
Schatman and Campbell (editors),
Taylor & Francis, 2007; 75-99,
What is the first thing you think
of treating when you have pain?
Pain
Taylor AG, Anderson JG, Riedel SL, Lewis JE, et al.
A randomized, controlled, double-blind pilot study of the effects of cranial electrical stimulation on activity in brain pain processing regions in individuals with fibromyalgia. Explore. 2013; 9(1): 32-40.
Pain in Fibromyalgia Patients
Pain
Lichtbroun, Alan S., Raicer, Mei-Ming C. and Smith, Ray B.
The treatment of fibromyalgia with cranial electrotherapy
stimulation. Journal of Clinical Rheumatology. 2001; 7(2): 72-78.
Cork, Randall C., Wood, Patrick, Ming, Norbert, Shepherd, Clifton, Eddy, James and Price, Larry. The effect of cranial electrotherapy stimulation
(CES) on pain associated with fibromyalgia.
The Internet Journal of Anesthesiology. 2004; 8(2).
Pain
Tan G, Rintala D, Herrington R, Yang J, Wade W, Vasilev C. and Shanti BF.
Treating spinal cord injury pain with cranial electrotherapy stimulation.
Journal of Spinal Cord Medicine. 2003; 26(3).
Active Sham
Pain Reduction in Advanced Cancer Patients
3.74
2.912.8 2.77
2.65
2
2.5
3
3.5
4
Baseline Week 1 Week 2 Week 3 Week 4
Mean pain scores in advanced cancer patients
Brief Pain InventoryN= 33p=0.013
Yennurajalingam S, Kang D-H, Hwu W-J, Padhye NS, Masino C, Dibaj SS, Liu DD, Williams JL, Lu Z, Bruera E. Cranial electrotherapy stimulation for the management of depression, anxiety, sleep disturbance, and pain in patients with advanced cancer: a preliminary study. Journal of Pain and Symptom
Management. 2018; 55(2): 198-206.
Pain
Rintala, Diana H., Tan, Gabriel, Willson, Pamela , Bryant, Mon S. and Lai, Eugene C. H. Feasibility of using cranial electrotherapy
stimulation for pain in persons with Parkinson’s disease. Parkinson’s Disease. 2010; 8 pages.
Authors’ Conclusion:
Use of CES at home by persons
With PD is feasible and helpful
in decreasing pain
Holubec, Jerry T. Cumulative Response from Cranial Electrotherapy Stimulation (CES) for Chronic Pain.
Practical Pain Management. 2009; 9(9): 80-83.
42%, N=525
50%, N=261
54%, N=160
64%, N=57
71%, N=26
40%
45%
50%
55%
60%
65%
70%
75%
1 2 3 4 5
CES Treatment Sessions
Pe
rce
nt
Re
du
ctio
n in
Pai
n L
eve
lsCumulative Improvement in Pain After 1-5 CES Treatments
Example of the CES Response Over Time
in a Patient with Severe MigraineCourtesy of COL Michael Singer, Walter Reed National Military Medical Center
Stay with it!
0
2
4
6
8
10
0 60 120 180
Pain Level
Minutes
fMRI RCT on CES Activity in Brain Pain
Processing Regions in Fibromyalgia Patients
Subjects using an active CES device showed deactivation in the pain processing regions of the brain compared to those using a sham device.
Taylor, Ann G., Anderson, Joel G., Riedel, Shannon L., Lewis, Janet E. and Bourguignon, Cheryl.
A randomized, controlled, double-blind pilot study of the effects of cranial electrotherapy stimulation on
activity in brain processing regions in individuals with fibromyalgia. Explore. 2013; 9(1): 32-49,
CES May Replace Medications
• CES may replace some medications
• Current medications may be potentiated by 1/3 to 1/2
• To reduce medication dosages
– Slowly taper, monitor symptoms, trial and error
Medication
CES
Time
Summary
• CES is safe
• CES is easy to use
• CES is proven effective
• CES works quickly and lasts
• CES is FDA, CFDA, CE and ISO certified
• US Military is using and researching CES
• CES is available to help you NOW!
Why Not Use CES?